Items where authors include "Tillett, W."

Article

McHugh, N., Tillett, W., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (7 more authors) (2024) Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Rheumatology. keae374. ISSN 1462-0324

Lyon, M. orcid.org/0000-0003-4845-1743, Zhao, S.S., Jani, M. orcid.org/0000-0002-1487-277X et al. (132 more authors) (2024) The influence of deprivation in the outcomes of psoriatic arthritis within the UK—utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology Advances in Practice, 8 (2). rkae051. ISSN 2514-1775

Coates, L.C., Bukhari, M., Chan, A. et al. (9 more authors) (2024) Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatology. keae172. ISSN 1462-0324

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Morris, A.P. orcid.org/0000-0002-6805-6014, Jani, M. orcid.org/0000-0002-1487-277X et al. (133 more authors) (2024) Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology Advances in Practice, 8 (1). rkae014. ISSN 2514-1775

Watson, M. orcid.org/0000-0001-8570-2113, Tillett, W. orcid.org/0000-0001-7531-4125, Jadon, D. et al. (7 more authors) (2024) The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease, 16. ISSN 1759-720X

Rombach, I. orcid.org/0000-0003-3464-3867, Tucker, L., Tillett, W. et al. (6 more authors) (2022) Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility study. Therapeutic Advances in Musculoskeletal Disease, 14. ISSN 1759-720X

Rombach, I. orcid.org/0000-0003-3464-3867, Tillett, W., Jadon, D. et al. (11 more authors) (2021) Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design. Trials, 22. 185. ISSN 1745-6215

Conference or Workshop Item

Tillett, W., Coates, L., Vis, M. et al. (7 more authors) (2023) POS1535 Early improvement in 3VAS/4VAS predicts reduced rates of radiographic change in bio-naive active psoriatic arthritis patients receiving Guselkumab treatment. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Wells, A.F., Kavanaugh, A., Tillett, W. et al. (7 more authors) (2024) Value of the Routine Assessment of Patient Index Data 3 in Assessing Disease Severity and Treatment Effect in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast. In: Arthritis & Rheumatology. ACR Convergence 2024, 14-19 Nov 2024, Washington, DC, USA. Wiley , pp. 1213-1215.

Helliwell, P., Coates, L., Ransom, M. orcid.org/0000-0003-4359-8287 et al. (5 more authors) (2023) AB1147 The Comparative Performance of Three Screening Questionnaires for Psoriatic Arthritis in a Primary Care Surveillance Program. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 1803-1804.

Mchugh, N., Bojke, L., Coates, L. et al. (7 more authors) (2023) OP0271 Incidence of Psoriatic Arthritis and Prevalence of Undiagnosed Cases in a UK Primary Care Population Followed Prospectively For 2 Years - Results from the TUDOR Randomized Clinical Trial. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 178-179.

Brown, S., Coates, L., Collier, H. et al. (6 more authors) (2023) POS0224 Enhanced Surveillance for the Detection of Psoriatic Arthritis in a UK Primary Care Psoriasis Population Versus Usual Care: Results at 24 Months from the the Total Burden of Psoriasis (TUDOR) Randomised Control Trial. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. Suppl 1, 82 . BMJ Publishing Group , pp. 339-340.

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2023) P176 Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2022) 1017: Minimal Important Difference (MID), Minimal Detectable Change (MDC),and Disease Activity Thresholds for Two Novel Composite Instruments(3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of ThreePhase 3 Studies. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2013-2015.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) 1268: Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2488-2490.

Tillett, W., Coates, L., Sharaf, M. et al. (7 more authors) (2022) 2142: Strong Correlation Between Short- vs Long-form Composite Measures ofPsoriatic Arthritis Disease Activity in a TNFi-IR Population Treated withGuselkumab: Data from the Phase 3b COSMOS Trial. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4248-4251.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) AB0904 Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1580-1581.

Tillett, W., Coates, L., Neuhold, M. et al. (6 more authors) (2022) POS1043 Strong Correlation Between Short- Vs Long-Form Composite Measures Of Psoriatic Arthritis Disease Activity In A TNFi-IR Population Treated With Guselkumab: Data From The Phase 3b Cosmos Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 838-839.